American Elements Logo and U.S. Registered Trademark
Gadolinia doped Ceria (GDC)
Cerium Oxide stabilized with Gadolinium Oxide
CeO2/Gd2O3
Product
Product Code
Order or Specifications
Gadolinia doped Ceria (Gd = 10%) Powder
CE-OX-02-GDC10-P
Contact American Elements
Gadolinia doped Ceria (Gd = 10%) Ink
CE-OX-02-GDC10-I
Contact American Elements
Gadolinia doped Ceria (Gd = 20%) Powder
CE-OX-02-GDC20-P
Contact American Elements
Gadolinia doped Ceria (Gd = 20%) Ink
CE-OX-02-GDC20-I
Contact American Elements
American Elements specializes in producing gadolinia doped ceria (GDC), cerium oxide stabilized by various doping levels of gadolinium oxide, solid oxide fuel cell cathode and electrolyte cross section by SEMa material that upon firing forms a highly ionically conductive thin film electrolyte layer for use in solid oxide fuel cell electrochemistry structures. Gadolinium Oxide doped Ceria belongs to a class of doped Ceria compounds with ionic conductivity exceeding Yttria Stabilized Zirconia (YSZ) electrolytes. These include Samarium doped Ceria (SDC) and Yttria doped Ceria (YDC). Even higher conductivity can be achieved with American Elements Scandia doped Zirconia (SCZ) and Yttria doped Bismuth Oxide. Gadolinium Oxide doped Cerium Oxide is available in a powder for tape casting, air spray, extrusion and sputtering fuel cell applications and as an ink for screen printing. Gadolinia doping levels are available at 10% and 20% and as specified by customer. American Elements provides guidance on firing parameters, doping levels, and thermal expansion matching with American Elements' cathode and anode cell layers.

Cerium is a Block F, Group 3, Period 6 element. The electronic configuration is [Xe]4f26s2. In its elemental form cerium's CAS number is 7440-45-1. The cerium atom has a radius of 182.5.pm and it's Van der Waals radius is 181.pm. Cerium is one of the products manufactured and distributed under the tradename AE Rare Earths. Cerium is the most abundant of the rare earths metals. It is characterized chemically by having two valence states , the +3 cerous and +4 ceric states. The ceric state is the only non-trivalent rare earth ion stable in aqueous solutions. It is, therefore, strongly acidic. It is also a strong oxidizer. The cerous state closely resembles the other trivalent rare earths. The numerous commercial applications for cerium include metallurgy, glass and glass polishing, ceramics, catalysts, as the electrolyte for solid oxide fuel cells when doped with yttrium, gadolinium or samarium and in phosphors. In steel manufacturing it is used to remove free oxygen and sulfur by forming stable oxysulfides and by tying up undesirable trace elements, such as lead and antimony. It is considered to be the most efficient glass polishing agent for precision optical polishing. It is also used to decolor glass by keeping iron in its ferrous state. The ability of cerium-doped glass to block out ultra violet light is utilized in the manufacturing of medical glassware and aerospace windows. It is also used to prevent polymers from darkening in sunlight and to suppress discoloration of television glass.

Formula CAS No. Appearance Molecular Weight Density Melting Point Boiling Point Solubility Stability
                 
PRODUCT CATALOG Cerium Research, Properties, & Information Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc. Fuel Cell
German   Korean   French   Japanese   Spanish   Chinese (Simplified)   Portuguese   Russian   Chinese (Taiwan)   Italian   Turkish   Polish   Dutch   Czech   Swedish   Hungarian   Danish   Hebrew

Production Catalog Available in 32 Countries
 
Periodic table of the elements science and academic information, elements and advanced materials data, scientific presentations and all pages, designs, concepts, logos, and color schemes herein are the copyrighted proprietary rights and intellectual property of American Elements. American Elements is a U.S. Registered Trademark. © 2001-2009. American Elements. All rights reserved.

 

Recent Research & Development for Gadolinium

  • Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Galldiks N, Ullrich R, Schroeter M, Fink GR, Kracht LW. Eur J Nucl Med Mol Imaging. 2009 Aug 7. [Epub ahead of print] PMID: 19662410 [PubMed - as supplied by publisher]

  • [MRI exploration for the evaluation of orbital implant biocolonization in children enucleated for retinoblastoma.] Douira-Khomsi W, Korchane N, Louati H, Bhouri L, Kchaou I, Ben Hassine L, Bouguila H, Ayed S, Bellagha I. J Fr Ophtalmol. 2009 Aug 4. [Epub ahead of print] French. PMID: 19660832 [PubMed - as supplied by publisher]

  • Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury. Shen J, Zhong XM, Duan XH, Cheng LN, Hong GB, Bi XB, Liu Y. Acad Radiol. 2009 Sep;16(9):1142-54. PMID: 19660710 [PubMed - in process]

  • Cerebral ischemia-reperfusion injury in rats-A 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. Pillai DR, Dittmar MS, Baldaranov D, Heidemann RM, Henning EC, Schuierer G, Bogdahn U, Schlachetzki F. J Cereb Blood Flow Metab. 2009 Aug 5. [Epub ahead of print] PMID: 19654585 [PubMed - as supplied by publisher]

  • Dynamic Contrast-Enhanced Perfusion MR Imaging With SPIO: A Pilot Study. Amemiya S, Akahane M, Aoki S, Abe O, Kamada K, Saito N, Ohtomo K. Invest Radiol. 2009 Jul 31. [Epub ahead of print] PMID: 19652616 [PubMed - as supplied by publisher]

  • [Spectroscopic analysis of Nd:GGG laser crystal] Zeng FM, Zhang Y, Sun J, Liu JH. Guang Pu Xue Yu Guang Pu Fen Xi. 2009 May;29(5):1323-6. Chinese. PMID: 19650481 [PubMed - in process]

  • A patient with acute myeloblastic leukemia who presented with conus medullaris syndrome and review of the literature. Olcay L, Arbas BK, Gökçe M. J Pediatr Hematol Oncol. 2009 Jun;31(6):440-7. PMID: 19648794 [PubMed - in process]

  • Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development. Chen J, Xu W, Zhou T, Ding Y, Duan J, Huang F. Parasite Immunol. 2009 Aug;31(8):466-73. PMID: 19646211 [PubMed - in process]

  • Feasibility of T(2) (*) mapping for the evaluation of hip joint cartilage at 1.5T using a three-dimensional (3D), gradient-echo (GRE) sequence: A prospective study. Bittersohl B, Hosalkar HS, Hughes T, Kim YJ, Werlen S, Siebenrock KA, Mamisch TC. Magn Reson Med. 2009 Jul 30. [Epub ahead of print] PMID: 19645008 [PubMed - as supplied by publisher]

  • Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM. Arthritis Rheum. 2009 Jul 30;61(8):1121-1129. [Epub ahead of print] PMID: 19644909 [PubMed - as supplied by publisher]

  • Potential side effects of gadolinium-enhanced MRI . Smith SM, Hoag SD. Am Fam Physician. 2009 Aug 1;80(3):214. No abstract available. PMID: 19642251 [PubMed - in process]

  • Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Kawate T, Michel JC, Birdsong WT, Gouaux E. Nature. 2009 Jul 30;460(7255):592-8. PMID: 19641588 [PubMed - indexed for MEDLINE]

  • Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. Greenwood JP, Maredia N, Radjenovic A, Brown JM, Nixon J, Farrin AJ, Dickinson C, Younger JF, Ridgway JP, Sculpher M, Ball SG, Plein S. Trials. 2009 Jul 29;10(1):62. [Epub ahead of print] PMID: 19640271 [PubMed - as supplied by publisher]

  • Motexafin gadolinium: a novel radiosensitizer for brain tumors. Francis D, Richards GM, Forouzannia A, Mehta MP, Khuntia D. Expert Opin Pharmacother. 2009 Jul 29. [Epub ahead of print] PMID: 19640206 [PubMed - as supplied by publisher]

  • Effect of intravenous gadolinium-DTPA on diffusion tensor MR imaging for the evaluation of brain tumors. Bae MS, Jahng GH, Ryu CW, Kim EJ, Choi WS, Yang DM. Neuroradiology. 2009 Jul 28. [Epub ahead of print] PMID: 19636547 [PubMed - as supplied by publisher]

  • Mural Inflammation in Crohn Disease: Location-Matched Histologic Validation of MR Imaging Features. Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Bloom S, Cohen R, Windsor A, Obichere A, Hansmann A, Novelli M, Halligan S, Taylor SA. Radiology. 2009 Jul 27. [Epub ahead of print] PMID: 19635832 [PubMed - as supplied by publisher]

  • Juxta-articular myxoma within the suprapatellar pouch masquerading as a ganglion cyst. Kosty JW, Moore JG. Orthopedics. 2009 Jul;32(7):527. doi: 10.3928/01477447-20090527-27. PMID: 19634839 [PubMed - in process]

  • The Evolution of Osseous Metaplasia in Localized Cutaneous Nephrogenic Systemic Fibrosis: A Case Report. Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W. Am J Dermatopathol. 2009 Jul 23. [Epub ahead of print] PMID: 19633532 [PubMed - as supplied by publisher]

  • Lumbar congestive myelopathy mimicking neoplasia without concurrent vascular malformation. Tsutsumi S, Abe Y, Yasumoto Y, Ito M. Neurol Med Chir (Tokyo). 2009 Jul;49(7):316-9. PMID: 19633406 [PubMed - in process]

  • Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Hombach V, Merkle N, Torzewski J, Kraus JM, Kunze M, Zimmermann O, Kestler HA, Wöhrle J. Eur Heart J. 2009 Jul 24. [Epub ahead of print] PMID: 19633015 [PubMed - as supplied by publisher]

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com